Antibodies to Nucleoprotein and to Hydrazide-altered Soluble Nucleoprotein in Tuberculous Patients Receiving Isoniazid

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 1969 Oct 1

PMID 5359961

Citations 8

Authors

D Alarcon-Segovia

E FISHBEIN

V M Betancourt

Affiliations

Soon will be listed here.

Citing Articles

Strain difference in the immune response to hydralazine in inbred guinea-pigs.

Ellman L, Inman J, Green I Clin Exp Immunol. 1971; 9(6):927-37.

PMID: 5316639 PMC: 1713137.

Studies on drug induced lupus erythematosus in mice. I. Drug induced antinuclear antibodies (ANA).

ten Veen J, FELTKAMP T Clin Exp Immunol. 1972; 11(2):265-76.

PMID: 4557182 PMC: 1553628.

Immunoglobulins in aqueous humour and iris from patients with endogenous uveitis and patients with cataract.

Ghose T, QUIGLEY J, Landrigan P, Asif A Br J Ophthalmol. 1973; 57(12):897-903.

PMID: 4207715 PMC: 1215210. DOI: 10.1136/bjo.57.12.897.

Antigenic specificity of chlorpromazine-induced antinuclear antibodies.

Alarcon-Segovia D, FISHBEIN E, Cetina J, Raya R, Barrera E Clin Exp Immunol. 1973; 15(4):543-8.

PMID: 4130538 PMC: 1553972.

Antinuclear antibodies in patients on anticonvulsant therapy.

Alarcon-Segovia D, FISHBEIN E, Reyes P, Dies H, SHWADSKY S Clin Exp Immunol. 1972; 12(1):39-47.

PMID: 4117275 PMC: 1553649.

References

ALARCON SEGOVIA D, WORTHINGTON J, WARD L, WAKIM K . LUPUS DIATHESIS AND THE HYDRALAZINE SYNDROME. N Engl J Med. 1965; 272:462-6. DOI: 10.1056/NEJM196503042720905. View

DUBOIS E, Tuffanelli D . CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. COMPUTER ANALYSIS OF 520 CASES. JAMA. 1964; 190:104-11. DOI: 10.1001/jama.1964.03070150014003. View

Russell A, ZIFF M . Natural antibodies to procaine amide. Clin Exp Immunol. 1968; 3(9):901-9. PMC: 1579007. View

DAMESHEK W . Systemic lupus erythematosus: a complex auto-immune disorder. Ann Intern Med. 1958; 48(4):707-30. DOI: 10.7326/0003-4819-48-4-707. View

Frost P, LACHMANN P . The relationship of desoxyribonuclease inhibitor levels in human sera to the occurrence of antinuclear antibodies. Clin Exp Immunol. 1968; 3(5):447-55. PMC: 1578906. View

Lee S, Rivero I, Siegel M . Activation of systemic lupus erythematosus by drugs. Arch Intern Med. 1966; 117(5):620-6. View

LAPPAT E, CAWEIN M . A familial study of procainamide-induced systemic lupus erythematosus. A question of pharmacogenetic polymorphism. Am J Med. 1968; 45(6):846-52. DOI: 10.1016/0002-9343(68)90183-6. View

Debeyre N, Kahn M, DE SEZE S . [Lupoid syndromes after absorption of isoniazid. Study of 6 cases]. Sem Hop. 1967; 43(49):3063-71. View

Allfrey V, Littau V, Mirsky A . METHODS FOR THE PURIFICATION OF THYMUS NUCLEI AND THEIR APPLICATION TO STUDIES OF NUCLEAR PROTEIN SYNTHESIS. J Cell Biol. 1964; 21:213-31. PMC: 2106442. DOI: 10.1083/jcb.21.2.213. View

10.

Siegel M, Lee S, Peress N . The epidemiology of drug-induced systemic lupus erythematosus. Arthritis Rheum. 1967; 10(5):407-15. DOI: 10.1002/art.1780100502. View

11.

ZINGALE S, MINZER L, Rosenberg B, Lee S . Drug induced lupus-like syndrome. Clinical and laboratory syndrome similar to systemic lupus erythematosus following antituberculous therapy: report of a case. Arch Intern Med. 1963; 112:63-6. DOI: 10.1001/archinte.1963.03860010109012. View

12.

Hackett E, BEECH M, FORBES I . Thyrogloubulin antibodies in patients without clinical disease of the thyroid gland. Lancet. 1960; 2(7147):402-4. DOI: 10.1016/s0140-6736(60)92842-7. View

13.

Cannat A, SELIGMANN M . Possible induction of antinuclear antibodies by isoniazid. Lancet. 1966; 1(7430):185-7. DOI: 10.1016/s0140-6736(66)90704-5. View

14.

Heimer R, Levin F, Rudd E . GLOBULINS RESEMBLING RHEUMATOID FACTOR IN SERUM OF THE AGED. Am J Med. 1963; 35:175-81. DOI: 10.1016/0002-9343(63)90208-0. View

15.

Irvine W, Davies S, Teitelbaum S, Delamore I, WILLIAMS A . The clinical and pathological significance of gastric parietal cell antibody. Ann N Y Acad Sci. 1965; 124(2):657-91. DOI: 10.1111/j.1749-6632.1965.tb18993.x. View

16.

SVEC K, Veit B . Age-related antinuclear factors: immunologic characteristics and associated clinical aspects. Arthritis Rheum. 1967; 10(6):509-16. DOI: 10.1002/art.1780100604. View

17.

HOLLEY H . EVIDENCE FOR A PREDISPOSITION TO RHEUMATIC DISEASES IN FAMILIES OF PATIENTS DEVELOPING DRUG-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS. Arthritis Rheum. 1964; 7:684-6. DOI: 10.1002/art.1780070608. View

18.

Tan E . An immunologic precipitin system between soluble nucleoprotein and serum antibody in systemic lupus erythematosus. J Clin Invest. 1967; 46(5):735-45. PMC: 297076. DOI: 10.1172/JCI105574. View

19.

ALARCON SEGOVIA D . [Role of various drugs in the activation of systemic lupus erythematosus]. Rev Invest Clin. 1966; 18(3):445-66. View

20.

Goudie R, ANDERSON J, GRAY K . Complement-fixing antithyroid antibodies in hospital patients with asymptomatic thyroid lesions. J Pathol Bacteriol. 1959; 77(2):389-400. DOI: 10.1002/path.1700770208. View